Salt Lake City, UT3 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Salt Lake City, UT

Find 3 actively recruiting duchenne muscular dystrophy clinical trials in Salt Lake City, UT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
2,592
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Salt Lake City

About Duchenne Muscular Dystrophy Clinical Trials in Salt Lake City

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 3 duchenne muscular dystrophy clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 2,592 participants. Research is being sponsored by The Duchenne Registry, University of Kansas Medical Center, Epicrispr Biotechnologies, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Salt Lake City — FAQ

Are there duchenne muscular dystrophy clinical trials in Salt Lake City?

Yes, there are 3 duchenne muscular dystrophy clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 3 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated July 19, 2026 from ClinicalTrials.gov